The effect of laughter therapy in patients with gastrointestinal cancers

Not Applicable

• Conditions: Malignant neoplasms of digestive organs.; Malignant neoplasms of digestive organs; C15-C26

• Registration Number: IRCT20200819048458N1
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Willingness to participate in the study
Having a gastrointestinal cancers
Existence of anxiety based on visual analog scale
Do not have audible and visual problems
Do not use radiotherapy along with chemotherapy

Exclusion Criteria

Discharge from the hospital
Death of the patient
Absence of the patient in laughter therapy sessions even once
increase or decrease the dose of anxiety medication during the intervention

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety in patients undergoing chemotherapy. Timepoint: 30 min before and 30 min after laughter therapy in both groups and daily for three days. Method of measurement: spilberger anxiety questionnaire.